1. "2013"
Formats
  1. Journal Article (2495)
  2. Meeting Abstract (1292)
  3. Book Section (250)
  4. Conference Paper (18)
  5. Book Whole (17)
  6. Review (1)
Groups
  1. Department of Medicine (1421)
  2. GSK Faculty (1000)
  3. Surgery (873)
  4. Solid Tumor Oncology Division (781)
  5. Survivorship Research (671)
  6. Sloan Kettering Institute Faculty (646)

More Groups

People
  1. Jose Baselga (74)
  2. Clifford Hudis (69)
  3. Jedd Wolchok (65)
  4. Howard Scher (62)
  5. Mithat Gonen (62)
  6. Ross Levine (62)

More People

Years
  1. 2013 (4073)
Publications
  1. Journal of Clinical Oncology (366)
  2. Blood (190)
  3. Cancer Research (119)
  4. International Journal of Radiation Oncology, Biology, Physics (88)
  5. Modern Pathology (88)
  6. Laboratory Investigation (81)

More Publications

Publishers
  1. Elsevier Inc. (502)
  2. American Society of Clinical Oncology (386)
  3. Springer (304)
  4. Nature Publishing Group (249)
  5. Elsevier Science, Inc. (206)
  6. American Society of Hematology (192)

More Publishers

Results (4073)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patterns of metastasis and survival in patients with PI3K-aberrant and FGFR1 amplified stage IV squamous cell lung cancers (SQCLCs)
    Meeting Abstract

    Paik, P. K.; Moreira, A. L.; Wang, L.; Rekhtman, N.; Sima, C. S.; Won, H.; Ladanyi, M.; Berger, M. F.; Kris, M. G.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Clinical benefit of continuing crizotinib beyond initial disease progression in patients with advanced ALK-positive non-small-cell lung cancer
    Meeting Abstract

    Ou, S. H. I.; Riely, G. J.; Tang, Y. Y.; Kim, D. W.; Otterson, G. A.; Crino, L.; Bartlett, C. H.; Cohen, D. P.; Clark, J. W.; Jänne, P. A.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Crizotinib therapy for patients with advanced ROS1-rearranged non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Ou, S. H. I.; Kim, D. W.; Camidge, D. R.; Riely, G.; Salgia, R.; Shapiro, G.; Solomon, B.; Engelman, J. A.; Kwak, E. L.; Clark, J. W.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Consistent therapeutic efficacy of CH5424802/RO5424802 in brain metastases among crizotinib-refractory ALK-positive non-small cell lung cancer (NSCLC) patients in an ongoing phase I/II study (AF-002JG/NP28761, NCT01588028)
    Meeting Abstract

    Ou, S. H. I.; Gadgeel, S.; Chiappori, A. A.; Gandhi, L.; Azada, M.; Garcia, L.; Takaya, I.; Yokoyama, S.; Kamei, T.; Tanaka, T.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Spread through alveolar spaces (STAS): A newly recognized pattern of invasion in lung adenocarcinoma associated with increased recurrence in patients undergoing limited resection for <= 2cm tumors
    Meeting Abstract

    Nitadori, J.; Kadota, K.; Sima, C. S.; Ujiie, H.; Rizk, N. P.; Rusch, V. W.; Travis, W. D.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Digital microscopy reproducibility study of thymic epithelial neoplasms
    Meeting Abstract

    Moreira, A. L.; Wang, H.; Sima, C. S.; Beasley, M. B.; Illei, P.; Saqi, A.; Nonaka, D.; Geisinger, K.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Dosimetric predictors of esophageal toxicity after stereotactic body radiotherapy for central lung tumors
    Meeting Abstract

    Modh, A.; Williams, E.; Rimner, A.; Foster, A.; Yorke, E.; Jackson, A.; Wu, A. J.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Determining read origin of next-generation sequencing datasets from lung cancer xenografts
    Meeting Abstract

    Marini, K.; Tothill, R.; Britt, K.; Falzon, J.; Li, J.; Bennett, S.; Tantoso, E.; Brown, T. J.; Martelotto, L.; Watkins, N.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Using synthetic lethal screening to identify therapeutic targets for innately platinum resistant lung cancer
    Meeting Abstract

    Marini, K.; Rossello, F.; Martelotto, L.; Watkins, N.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Inhibition of the IGF-1R signaling pathway potentiates responses to ALK inhibitors in both ALK TKI naive and ALK TKI resistant lung cancer
    Meeting Abstract

    Lovly, C. M.; McDonald, N. T.; Chen, Y. L. H.; Jin, H. L.; Lim, D.; Suehara, Y.; Wang, L.; Johnson, D. H.; Horn, L.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save